Study Uncovers Disproportionate Infection Signals Linked to Specific Multiple Sclerosis Therapies
A pharmacovigilance analysis of over one million adverse event reports found disproportionate reporting signals for progressive multifocal leukoencephalopathy with natalizumab ...










